Bill Texts: NJ S4051 | 2018-2019 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2019-08-23 - Introduced in the Senate, Referred to Senate Commerce Committee [S4051 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2019-08-23HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey S4051

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey S4051 currently on file.

Social Comments on NJ S4051

feedback